Lee T. Bacheler

4.9k total citations · 1 hit paper
82 papers, 3.8k citations indexed

About

Lee T. Bacheler is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Lee T. Bacheler has authored 82 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Infectious Diseases, 67 papers in Virology and 20 papers in Molecular Biology. Recurrent topics in Lee T. Bacheler's work include HIV Research and Treatment (67 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (26 papers). Lee T. Bacheler is often cited by papers focused on HIV Research and Treatment (67 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (26 papers). Lee T. Bacheler collaborates with scholars based in United States, United Kingdom and Canada. Lee T. Bacheler's co-authors include Susan Erickson‐Viitanen, Ronald M. Klabe, Beverly C. Cordova, Chong‐Hwan Chang, Marlene M. Rayner, Prabhakar K. Jadhav, Michaël Otto, James L. Meek, H Fan and Sena Garber and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Lee T. Bacheler

81 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors

1994 680 citations Patrick Y. S. Lam, Prabhakar K. Jadhav et al. profile →

Peers

Lee T. Bacheler

VIROL

EPIDE

Daniel W. Norbeck United States

D.K. Stammers United Kingdom

W. Gary Tarpley United States

Arne Schön United States

Warren M. Kati United States

Paul L. Darke United States

J. M. Cameron United Kingdom

Marı́a-José Camarasa Spain

Yasuhiro Koh United States

Arthur D. Clark United States

Daniel W. Norbeck United States

Lee T. Bacheler

2.9k ×1.4

2.5k ×1.2

VIROL

1.2k ×1.0

1.4k ×1.3

484 ×1.4

EPIDE

Citations per year, relative to Lee T. Bacheler Lee T. Bacheler (= 1×) peers Daniel W. Norbeck

Countries citing papers authored by Lee T. Bacheler

Since Specialization

Citations

This map shows the geographic impact of Lee T. Bacheler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee T. Bacheler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee T. Bacheler more than expected).

Fields of papers citing papers by Lee T. Bacheler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee T. Bacheler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee T. Bacheler. The network helps show where Lee T. Bacheler may publish in the future.

Co-authorship network of co-authors of Lee T. Bacheler

This figure shows the co-authorship network connecting the top 25 collaborators of Lee T. Bacheler. A scholar is included among the top collaborators of Lee T. Bacheler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee T. Bacheler. Lee T. Bacheler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Hua, et al.. (2010). The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations. Virology. 402(2). 228–237. 12 indexed citations

Houtte, Margriet Van, Gastón Picchio, Koen Van der Borght, et al.. (2009). A comparison of HIV‐1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype. Journal of Medical Virology. 81(10). 1702–1709. 25 indexed citations

Sista, Prakash, et al.. (2009). Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals. Journal of Clinical Virology. 44(3). 190–194. 8 indexed citations

Demeter, Lisa M., Hongyu Jiang, Aprateem Mukherjee, et al.. (2009). A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients. AIDS. 23(3). 357–368. 14 indexed citations

Harrigan, P. Richard, et al.. (2007). A 21-Base Pair Insertion/Duplication at Codon 69 of the HIV Type 1 Reverse Transcriptase in a Patient Undergoing Multiple Nucleoside Therapy. AIDS Research and Human Retroviruses. 23(7). 895–899. 4 indexed citations

Houtte, Margriet Van, et al.. (2006). NRTI resistance associated with the RT mutation K70E in HIV-1. Antiviral Therapy. 11(5). 3 indexed citations

Abecasis, Ana, Koen Deforche, Joke Snoeck, et al.. (2006). Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G (vol 20, pg 1789, 2006). 1 indexed citations

Harrigan, P. Richard, Theresa Mo, Brian Wynhoven, et al.. (2005). Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. AIDS. 19(6). 549–554. 34 indexed citations

Vermeiren, Hans, Tim Van den Bulcke, Herwig Van Marck, et al.. (2004). Application of multiple linear regression modelling to the quantitative prediction of HIV-1 drug susceptibility phenotype from viral genotype. Antiviral Therapy. 9(4). 2 indexed citations

10.

Hsu, Li Yang, et al.. (2004). Characterization of Mutations in CRF01_AE Virus Isolates From Antiretroviral Treatment-Naive and -Experienced Patients in Singapore. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(1). 5–13. 28 indexed citations

11.

Marck, Herwig Van, Tim Van den Bulcke, Margriet Van Houtte, Pierre Lecocq, & Lee T. Bacheler. (2003). Quantitative prediction of HIV drug susceptibility from viral genotype through linear regression modelling. Antiviral Therapy. 8(3). 2 indexed citations

12.

Cocuzza, Anthony J., Dennis R. Chidester, Beverly C. Cordova, et al.. (2001). Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain. Bioorganic & Medicinal Chemistry Letters. 11(9). 1177–1179. 67 indexed citations

13.

Patel, Mona, Robert J. McHugh, Beverly C. Cordova, et al.. (2001). Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(14). 1943–1945. 81 indexed citations

14.

Rodgers, James D., Patrick Y. S. Lam, Barry L. Johnson, et al.. (1998). Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Chemistry & Biology. 5(11). R312–R312. 1 indexed citations

15.

Patel, Mona, Robert F. Kaltenbach, David A. Nugiel, et al.. (1998). The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(9). 1077–1082. 19 indexed citations

16.

Rodgers, James D., Barry L. Johnson, Susan Erickson‐Viitanen, et al.. (1998). Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups. Bioorganic & Medicinal Chemistry Letters. 8(7). 715–720. 34 indexed citations

17.

Patel, Mona, Lee T. Bacheler, Marlene M. Rayner, et al.. (1998). The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues. Bioorganic & Medicinal Chemistry Letters. 8(7). 823–828. 16 indexed citations

18.

Winslow, Dean L., Elizabeth D. Anton, Robert A. Horlick, et al.. (1994). Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the Protease Gene. Biochemical and Biophysical Research Communications. 205(3). 1651–1657. 11 indexed citations

19.

Hart, Clyde E., J C Galphin, Chin‐Yih Ou, et al.. (1991). Human Chromosome-Dependent and -Independent Pathways for HIV-2 Trans-Activation. AIDS Research and Human Retroviruses. 7(11). 877–882. 8 indexed citations

20.

Durda, Paul J., Lee T. Bacheler, Paul R. Clapham, et al.. (1990). HIV-1 Neutralizing Monoclonal Antibodies Induced by a Synthetic Peptide. AIDS Research and Human Retroviruses. 6(9). 1115–1123. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact